Advanced Filters
noise

ankylosing-spondylitis Clinical Trials

A listing of ankylosing-spondylitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 39 clinical trials
Z Zhanguo Li

Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study.

18 - 70 years of age Both Phase 2

A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

This is a randomized, double-blind, placebo-controlled, multi-center phase III clinical study to evaluate the efficacy and safety of AK111 in the treatment of subjects with active ankylosing spondylitis.

18 - 100 years of age Both Phase 3

Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT

To evaluate the potential usefulness of 68Ga-FAPI PET/CT for the diagnosis, inflammation evaluation and prognosis prediction in spondyloarthritis.

18 - 65 years of age Both Phase N/A
S Stefan Siebert

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis

People with axial spondyloarthritis (axSpA) often have intestinal inflammation and intestinal microbiome dysbiosis, with some similarities to Crohn's-like inflammatory bowel disease (IBD) gut inflammation. However, research has not addressed whether Partial Enteral Nutrition (PEN), a diet formed of a liquid formula and some solid whole foods, which is effective at …

16 - 100 years of age Both Phase N/A
S Songul B Yentur

Telerehabilitation in Ankylosing Spondylitis

Ankylosing Spondylitis (AS) is an inflammatory rheumatic disease primarily affecting the spine and sacroiliac joint. xercise is one of the most important nonpharmacologic treatment modalities in AS. Stretching, strengthening, aerobic, posture, balance and moltimodal exercise methods are the most commonly used treatment methods. The study will include 44 patients diagnosed …

18 - 65 years of age Both Phase N/A
B Baijie Xu, PhD.

A Clinical Study of JS005 in Patients With Ankylosing Spondylitis

This is a multicentre, randomized, double-blind, parallel, placebo-controlled Phase II clinical study of 261 adults with active ankylosing spondylitis to evaluate the efficacy and safety of JS005 in the treatment of active ankylosing spondylitis.

18 - 75 years of age Both Phase 2
C Chunde Bao

Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, efficacy and safety study of Jaktinib in subjects with active Ankylosing Spondylitis(AS).

18 - 65 years of age Both Phase 3
G Gunnstein Bakland, MD PhD

Fecal Microbiota Transplantation in Axial Spondyloarthritis

Although biologic therapy have revolutionized the treatment of Spondyloarthrtitis (SpA), many patients do not experience complete relief of SpA related complaints. It has been established that patients with SpA have an altered composition of microorganisms (microbiota) in the gut compared to healthy controls, and that this correlates to disease activity …

18 - 65 years of age Both Phase 2
C Chunde Bao

Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)

The purpose of this study is to determine if Jaktinib is safe and effective in participants with active ankylosing spondylitis.

18 - 65 years of age Both Phase 3
L Lise Laclautre

Impact of a Gluten-free Diet on Quality of Life in Patients With Axial Spondyloarthritis.

Subclinical intestinal inflammation and gut dysbiosis have been reported in patients with spondyloarthritis (SpA). In common practice, rheumatologists are increasingly confronted with patients with inflammatory rheumatism who are on gluten-free diets (GFDs), despite the lack of reliable data from controlled studies. This study aims to determine the impact of a …

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI